Literature DB >> 7534289

Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk.

D Beitner-Johnson1, D LeRoith.   

Abstract

Crk, a cellular homolog of v-crk, is an SH2 and SH3 domain-containing adaptor protein related to Grb2 and Nck, two proteins which have been shown to be involved in growth factor signal transduction. Crk proteins have recently been found to associate with two guanine nucleotide releasing proteins, mSos and C3G, and thus appear to lie on the Ras pathway. We investigated whether Crk is a target for the insulin-like growth factor I (IGF-I) receptor tyrosine kinase. We show that IGF-I stimulates tyrosine phosphorylation of Crk II via stimulation of endogenous IGF-I receptors in both 293 cells and NIH-3T3 cells. IGF-I stimulated tyrosine phosphorylation of Crk II in a dose- and time-dependent manner. In 293 cells, which express both IGF-I and insulin receptors, insulin also induced a dose-dependent tyrosine phosphorylation of Crk II, but with somewhat reduced sensitivity, compared to IGF-I. In NIH 3T3 cells, IGF-I also stimulated tyrosine phosphorylation of a 45- kDa protein which co-immunoprecipitated with Crk II. These findings indicate that Crk II is an endogenous substrate of the IGF-I receptor tyrosine kinase and provide the first demonstration that a mitogenic growth factor induces tyrosine phosphorylation of endogenous c-Crk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534289     DOI: 10.1074/jbc.270.10.5187

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

2.  Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of the Grb2-SOS and CrkII-C3G complexes.

Authors:  S Okada; M Matsuda; M Anafi; T Pawson; J E Pessin
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

Review 3.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

4.  RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.

Authors:  Ulrich Hermanto; Cong S Zong; Weiqun Li; Lu-Hai Wang
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.

Authors:  A P Koval; V A Blakesley; C T Roberts; Y Zick; D Leroith
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  The beta-subunit of the hepatocyte growth factor/scatter factor (HGF/SF) receptor phosphorylates and associates with CrkII: expression of CrkII enhances HGF/SF-induced mitogenesis.

Authors:  S M Riordan; S Lidder; R Williams; G G Skouteris
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

7.  The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts.

Authors:  L Laviola; F Giorgino; J C Chow; J A Baquero; H Hansen; J Ooi; J Zhu; H Riedel; R J Smith
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.

Authors:  M Ariga; T Nedachi; M Akahori; H Sakamoto; Y Ito; F Hakuno; S Takahashi
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

9.  Cell type influences the molecular mechanisms involved in hormonal regulation of ERG K+ channels.

Authors:  Luis Carretero; Francisco Barros; Pablo Miranda; Jorge Fernández-Trillo; Angeles Machín; Pilar de la Peña; Pedro Domínguez
Journal:  Pflugers Arch       Date:  2012-03-14       Impact factor: 3.657

Review 10.  IGF-I receptor, cell-cell adhesion, tumour development and progression.

Authors:  Loredana Mauro; Eva Surmacz
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.